Allergy Clinical Trials

Dry, Itchy, Red Skin? It may be Eczema! Interested in clinical research on eczema with an experimental oral medication?  

Researchers at the University of Kentucky are inviting you to participate in a study to see if your lung tissue temperature increases when exposed to something you are allergic to such as ragweed, house dust mite, or cat dander.

The OXFORAD™ Study for Atopic Dermatitis is examining an investigational drug to see how safe and effective it is when given to people like you who have eczema.

The purpose of the trial is to test if the trial drug, tralokinumab, is better than placebo or ‘dummy treatment’ at treating moderate to severe atopic dermatitis. This will be judged by a range of assessments that rate the severity and extent of atopic dermatitis, itch and several other symptoms, ...

The main purpose of this study is to compare the safety, efficacy, and tolerability of a once-daily topical application of IDP-123 Lotion compared to the IDP-123 Vehicle Lotion in subjects with moderate to severe acne. Subjects must be at least 9 years of age or older and generally healthy. IDP-123 ...

A Prospective, vehicle-controlled, double blind, multicenter, randomized phase II study of B244 delivered as a topical spray to determine safety in subjects with mild to moderate atopic dermatitis.

Unhappy with your options for eczema? Considering different options? Wake Research is enrolling volunteers in a study of the efficacy, safety and tolerability of an investigational ointment for mild to moderate eczema, also called atopic dermatitis. Your participation in the study could last up to three months. You’ll receive study-related ...

“I Just Can’t Stop Scratching.” If you’ve said this to yourself before, you might qualify for a clinical study for a new investigational oral medication for the itching associated with atopic dermatitis. Atopic dermatitis patients have difficulty with a variety of symptoms including itch and excessive scratching, lesions, scaring, infection, ...

A randomised, double-blind, placebo-controlled trial to evaluate the effect of tralokinumab on vaccine antibody responses in adults with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy.  

Chronic itch associated with Prurigo Nodularis